Upgrade to SI Premium - Free Trial

Unusual 11 Mid-Day Movers 8/18: (EARS) (CERU) (CXW) Higher; (SEMI) (CIE) (CSIQ) Lower

August 18, 2016 12:56 PM
Auris Medical Holding AG (Nasdaq: EARS) 61.4% LOWER; announced top-line results from the Phase 3 TACTT2 trial with Keyzilen (AM-101) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles